Headline Roundup February 24, 2021
Johnson & Johnson Vaccine Is Safe and Effective, FDA Analysis Finds
Summary from the AllSides News Team
Featured Coverage of this Story
New York Post (News)
The Food and Drug Administration backed Johnson & Johnson’s single-dose coronavirus vaccine as safe and effective on Wednesday as the agency weighs whether to clear the shot for emergency use.
FDA staff affirmed J&J’s finding that the vaccine was 66 percent effective overall at warding off moderate and severe COVID-19 cases and 85 percent effective at preventing the most serious infections.
While not as strong as Pfizer and Moderna’s two-dose vaccines, that efficacy rate could still make J&J’s shot a helpful weapon in the battle against the pandemic. It’s also...
Axios
The Food and Drug Administration's staff released a briefing document on Wednesday endorsing Johnson & Johnson's one-shot coronavirus vaccine as safe and effective.
The latest: Assuming the FDA issues an emergency use authorization "without delay," meaning as soon as this weekend, White House coronavirus coordinator Jeff Zients said J&J will have 3 million to 4 million ready for distribution next week.
What's next: An FDA advisory panel will meet Friday to review the briefing document and vote on whether to recommend an emergency use authorization (EUA). The FDA will then...
NBC News Digital
Documents released by the Food and Drug Administration on Wednesday indicate that Johnson & Johnson's Covid-19 vaccine is overall safe and highly effective — 86 percent — against the most severe outcomes of the illness.
The favorable review comes two days before a panel of independent advisers to the FDA is scheduled to discuss the company's application for emergency use. It is widely expected that the Vaccines and Related Biological Products Advisory Committee, or VRBPAC, will vote to recommend authorization of the vaccine.
AllSides Picks
Blog
Media Bias Alert: DOJ Claims Biden Admin Weaponized Gov’t to ‘Chill Free Speech’ Despite Internal Dissent
Andy Gorel
October 8th, 2026
Red Blue Translator
Anti-vaxxer
Headline Roundup
Pollsters Face Obstacles as 2026 Midterms Approach
November 2nd, 2026
Blog
Villain or Hero? How the Left and Right Covered the Lone Holdout Juror in the Lindsay Clancy Trial
Jamie Krstev
November 3rd, 2026
